Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma

about

Targeting the RhoGTPase/ROCK pathway for the treatment of VHL/HIF pathway-driven cancers.CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.VHL and Hypoxia Signaling: Beyond HIF in Cancer.

P2860

Q38668940-6A01689A-4FF2-4FA3-AD80-05A58F430634 Q46085514-E8932BCD-C63F-46E2-814A-05412C9E1554 Q54943750-4BE10168-B13A-49B1-B4E0-7C7E47CCAF7F

P2860

Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma

Item

http://www.wikidata.org/entity/Q36191526

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Rho-associated kinase 1 inhibi ...... lear cell renal cell carcinoma

@ast

Rho-associated kinase 1 inhibi ...... lear cell renal cell carcinoma

@en

type

Item

label

Rho-associated kinase 1 inhibi ...... lear cell renal cell carcinoma

@ast

Rho-associated kinase 1 inhibi ...... lear cell renal cell carcinoma

@en

prefLabel

Rho-associated kinase 1 inhibi ...... lear cell renal cell carcinoma

@ast

Rho-associated kinase 1 inhibi ...... lear cell renal cell carcinoma

@en

P1476

Rho-associated kinase 1 inhibi ...... lear cell renal cell carcinoma

@en

P2093

A C Liao

http://www.w3.org/2001/XMLSchema#string

I Nesterenko

http://www.w3.org/2001/XMLSchema#string

J M Thompson

http://www.w3.org/2001/XMLSchema#string

L J Nelson

http://www.w3.org/2001/XMLSchema#string

M Singh

http://www.w3.org/2001/XMLSchema#string

M W Pavesic

http://www.w3.org/2001/XMLSchema#string

O V Razorenova

http://www.w3.org/2001/XMLSchema#string

Q H Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells

Axitinib for the management of metastatic renal cell carcinoma

State of the science: an update on renal cell carcinoma

RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer

Targeting HIF-1 for cancer therapy

Cancer statistics, 2014

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Sorafenib in advanced clear-cell renal-cell carcinoma

P2888

onc.2016.272

P304

1080-1089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2016.272

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003643864

http://www.w3.org/2001/XMLSchema#string

P698

27841867

http://www.w3.org/2001/XMLSchema#string

P932

5323317

http://www.w3.org/2001/XMLSchema#string

Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma

about

P2860

P2860

Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932